Cargando…
The challenges of introducing routine G6PD testing into radical cure: a workshop report
The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative and a quantitative...
Autores principales: | Ley, Benedikt, Luter, Nick, Espino, Fe Esperanza, Devine, Angela, Kalnoky, Michael, Lubell, Yoel, Thriemer, Kamala, Baird, J. Kevin, Poirot, Eugenie, Conan, Nolwenn, Kheong, Chong Chee, Dysoley, Lek, Khan, Wasif Ali, Dion-Berboso, April G., Bancone, Germana, Hwang, Jimee, Kumar, Ritu, Price, Ric N., von Seidlein, Lorenz, Domingo, Gonzalo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587750/ https://www.ncbi.nlm.nih.gov/pubmed/26416229 http://dx.doi.org/10.1186/s12936-015-0896-8 |
Ejemplares similares
-
Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017) -
Methods for the field evaluation of quantitative G6PD diagnostics: a review
por: Ley, Benedikt, et al.
Publicado: (2017) -
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study
por: Ley, Benedikt, et al.
Publicado: (2016) -
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
por: Devine, Angela, et al.
Publicado: (2017) -
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
por: Thriemer, Kamala, et al.
Publicado: (2021)